C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes

Diabetologia

Volumn 54, Issue 10, 2011, Pages 2713-2723

  Liu, F ^b   Chen, H Y ^a   Huang, X R ^a   Chung, A C K ^a   Zhou, L ^b   Fu, P ^b   Szalai, A J ^c   Lan, H Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN UNIVERSITY   (China)

^c University of Alabama at Birmingham   (United States)

Author keywords

CRP; Diabetic nephropathy; Fibrosis; Inflammation; NF B; TGF SMAD

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; FC RECEPTOR IIA; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; SMAD3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUSAL ATTRIBUTION; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FIBROSIS; MACROPHAGE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STREPTOZOCIN DIABETES; T LYMPHOCYTE; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; C-REACTIVE PROTEIN; CELL LINE; CHEMOKINE CCL2; CONNECTIVE TISSUE GROWTH FACTOR; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80054116064     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2237-y     Document Type: Article

References (43)

1. JF Navarro-Gonzalez C Mora-Fernandez 2008 The role of inflammatory cytokines in diabetic nephropathy J Am Soc Nephrol 19 433 442 18256353 10.1681/ASN.2007091048 1:CAS:528:DC%2BD1cXktVamsbc%3D (Pubitemid 351355386)
2. M Saraheimo AM Teppo C Forsblom J Fagerudd PH Groop 2003 Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients Diabetologia 46 1402 1407 12928771 10.1007/s00125-003-1194-5 1:CAS:528:DC%2BD3sXnvVCgur8%3D (Pubitemid 37297211)
3. KR Tuttle 2005 Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease J Am Soc Nephrol 16 1537 1538 15872083 10.1681/ASN.2005040393 (Pubitemid 41716459)
4. AD Pradhan JE Manson N Rifai JE Buring PM Ridker 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 327 334 11466099 10.1001/jama.286.3.327 1:STN:280:DC%2BD3MvisVCmug%3D%3D (Pubitemid 32656163)
5. CG Schalkwijk DC Poland W van Dijk, et al. 1999 Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation Diabetologia 42 351 357 10096789 10.1007/s001250051162 1:CAS:528:DyaK1MXhsVyis7s%3D (Pubitemid 29111443)
6. A Pfutzner T Forst 2006 High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus Diabetes Technol Ther 8 28 36 16472048 10.1089/dia.2006.8.28
7. PM Ridker 2009 C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease Clin Chem 55 209 215 19095723 10.1373/clinchem.2008.119214 1:CAS:528:DC%2BD1MXhvVWksrk%3D
8. H Abrahamian G Endler M Exner, et al. 2007 Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines Exp Clin Endocrinol Diabetes 115 38 41 17286233 10.1055/s-2007-948213 1:CAS:528:DC%2BD2sXislygsLw%3D (Pubitemid 46293410)
9. CD Stehouwer MA Gall JW Twisk E Knudsen JJ Emeis HH Parving 2002 Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death Diabetes 51 1157 1165 11916939 10.2337/diabetes.51.4.1157 1:CAS:528:DC%2BD38Xis1Oisro%3D (Pubitemid 34438363)
10. C Sabanayagam J Lee A Shankar SC Lim TY Wong ES Tai 2009 C-reactive protein and microalbuminuria in a multi-ethnic Asian population Nephrol Dial Transplant 25 1167 1172 19914996 10.1093/ndt/gfp591
11. RB Goldberg 2009 Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications J Clin Endocrinol Metab 94 3171 3182 19509100 10.1210/jc.2008-2534 1:CAS:528:DC%2BD1MXhtFCht7nI
12. Y Mugabo L Li G Renier 2010 The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings Current Diabetes Reviews 6 27 34 20034371 10.2174/157339910790442628 1:CAS:528: DC%2BC3cXislOqu78%3D
13. MB Pepys GM Hirschfield GA Tennent, et al. 2006 Targeting C-reactive protein for the treatment of cardiovascular disease Nature 440 1217 1221 16642000 10.1038/nature04672 1:CAS:528:DC%2BD28XjvVGltLY%3D
14. PM Ridker 2009 The JUPITER trial: results, controversies, and implications for prevention Circulation 2 279 285 20031849
15. PM Ridker E Danielson FA Fonseca, et al. 2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2195 2207 18997196 10.1056/NEJMoa0807646 1:CAS:528:DC%2BD1cXhtl2gurnL
16. HD Danenberg AJ Szalai RV Swaminathan, et al. 2003 Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice Circulation 108 512 515 12874178 10.1161/01.CIR.0000085568.13915.1E 1:CAS:528: DC%2BD3sXlvVWqsbk%3D (Pubitemid 36961161)
17. A Paul KW Ko L Li, et al. 2004 C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice Circulation 109 647 655 14744975 10.1161/01.CIR.0000114526.50618.24 1:CAS:528: DC%2BD2cXos1emtQ%3D%3D (Pubitemid 38198873)
18. R Zhang YY Zhang XR Huang, et al. 2010 C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease Hypertension 55 953 960 20157054 10.1161/HYPERTENSIONAHA.109.140608 1:CAS:528:DC%2BC3cXktFOrs7w%3D
19. FC Brosius 3rd CE Alpers EP Bottinger, et al. 2009 Mouse models of diabetic nephropathy J Am Soc Nephrol 20 2503 2512 19729434 10.1681/ASN. 2009070721
20. AJ Szalai MA McCrory 2002 Varied biologic functions of C-reactive protein: lessons learned from transgenic mice Immunologic research 26 279 287 12403365 10.1385/IR:26:1-3:279 1:CAS:528:DC%2BD38Xos1CisL8%3D (Pubitemid 35177504)
21. HY Lan W Mu DJ Nikolic-Paterson RC Atkins 1995 A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens J Histochem Cytochem 43 97 102 7822770 10.1177/43.1.7822770 1:CAS:528:DyaK2MXjtFKltbs%3D
22. XR Huang AC Chung L Zhou XJ Wang HY Lan 2008 Latent TGF-beta1 protects against crescentic glomerulonephritis J Am Soc Nephrol 19 233 242 18216320 10.1681/ASN.2007040484 1:CAS:528:DC%2BD1cXivFKqsbk%3D (Pubitemid 351240645)
23. AC Chung XR Huang L Zhou R Heuchel KN Lai HY Lan 2009 Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice Nephrol Dial Transplant 24 1443 1454 19096081 10.1093/ndt/gfn699 1:CAS:528:DC%2BD1MXkvFKjsbw%3D
24. SW Hong M Isono S Chen MC Iglesias-De La Cruz DC Han FN Ziyadeh 2001 Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse Am J Pathol 158 1653 1663 11337363 10.1016/S0002-9440(10)64121-1 1:STN:280:DC%2BD3MzlsF2jtA%3D%3D (Pubitemid 32422930)
25. JH Li XR Huang HJ Zhu, et al. 2004 Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease Faseb J 18 176 178 12709399 10.1096/fj.04-2273com 1:CAS:528:DC%2BD2cXlvFOqsg%3D%3D (Pubitemid 39610507)
26. S Mezzano C Aros A Droguett, et al. 2004 NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy Nephrol Dial Transplant 19 2505 2512 15280531 10.1093/ndt/gfh207 1:CAS:528: DC%2BD2cXnvVOlt7k%3D (Pubitemid 39360096)
27. M Fujimoto Y Maezawa K Yokote, et al. 2003 Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy Biochem Biophys Res Commun 305 1002 1007 12767930 10.1016/S0006-291X(03)00885-4 1:CAS:528:DC%2BD3sXktFGisrc%3D (Pubitemid 36597863)
28. A Wang FN Ziyadeh EY Lee, et al. 2007 Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria Am J Physiol 293 F1657 F1665 10.1152/ajprenal.00274.2007 1:CAS:528:DC%2BD2sXhtlGhtrjE (Pubitemid 350086003)
29. SP Ballou G Lozanski 1992 Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein Cytokine 4 361 368 1420997 10.1016/1043-4666(92)90079-7 1:CAS:528:DyaK3sXmt1Cisbw%3D
30. D Hanriot G Bello A Ropars, et al. 2008 C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes Thromb Haemost 99 558 569 18327405 1:CAS:528:DC%2BD1cXnvVSku74%3D (Pubitemid 351549293)
31. YJ Liang KG Shyu BW Wang LP Lai 2006 C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells J Mol Cell Cardiol 40 412 420 16430914 10.1016/j.yjmcc.2005. 12.008 1:CAS:528:DC%2BD28XhvVWqsrY%3D (Pubitemid 43277843)
32. C Mold TW Du Clos 2006 C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors J Immunol 176 7598 7604 16751406 1:CAS:528:DC%2BD28Xlt1Cks7g%3D (Pubitemid 43853054)
33. H Guan P Wang R Hui, et al. 2009 Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats Clin Chem 55 274 284 19056836 10.1373/clinchem.2008.115857 1:CAS:528:DC%2BD1MXhvVWks7o%3D
34. V Pasceri J Chang J Willerson, et al. 2001 Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2531 2534 11382718 1:CAS:528:DC%2BD3MXltVSnur8%3D (Pubitemid 32521959)
35. JH Li XR Huang HJ Zhu R Johnson HY Lan 2003 Role of TGF-beta signaling in extracellular matrix production under high glucose conditions Kidney Int 63 2010 2019 12753288 10.1046/j.1523-1755.2003.00016.x 1:CAS:528: DC%2BD3sXkvVyiurs%3D (Pubitemid 36605812)
36. K Sharma Y Jin J Guo FN Ziyadeh 1996 Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice Diabetes 45 522 530 8603776 10.2337/diabetes.45.4.522 1:CAS:528:DyaK28Xjs1Gjuro%3D
37. FN Ziyadeh BB Hoffman DC Han, et al. 2000 Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice Proc Natl Acad Sci USA 97 8015 8020 10859350 10.1073/pnas.120055097 1:CAS:528:DC%2BD3cXkvFCmsr0%3D (Pubitemid 30460765)
38. B Lu Y Yang Z Yang, et al. 2010 Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity Cardiovasc Diabetol 9 92 21167068 10.1186/1475-2840-9-92 1:CAS:528:DC%2BC3MXmtFw%3D
39. Kaneko H, Anzai T, Nagai T et al. (2011) Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling. Cardiovasc Res. doi: 10.1093/cvr/cvr088
40. K Tanigaki C Mineo IS Yuhanna, et al. 2009 C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1 Circ Res 104 1275 1282 19423845 10.1161/CIRCRESAHA.108.192906 1:CAS:528:DC%2BD1MXms1Wksrs%3D
41. T Takahashi T Anzai H Kaneko, et al. 2010 Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction Am J Physiol Heart Circ Physiol 299 H1795 H1804 20852043 10.1152/ajpheart.00001.2010 1:CAS:528:DC%2BC3cXhs1elsL%2FF
42. W Vongpatanasin GD Thomas R Schwartz, et al. 2007 C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice Circulation 115 1020 1028 17283257 10.1161/CIRCULATIONAHA. 106.664854 1:CAS:528:DC%2BD2sXhvVyqur0%3D (Pubitemid 46328296)
43. K Han KH Hong JH Park, et al. 2004 C-Reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes Circulation 109 2566 2571 15136507 10.1161/01.CIR.0000131160.94926.6E 1:CAS:528:DC%2BD2cXkt1ars7o%3D (Pubitemid 38720558)